Leprosy: Paucibacillary or Multibacillary, and the MDT Regimen (WHO 2018)
Classifies leprosy as paucibacillary or multibacillary by WHO 2017 definitions and gives the 2018 MDT.
Open the tool → Runs in your browser. Data leaves only if you deliberately send a problem report from the interactive tool.
Example
- Number of skin lesions
- 3
- Nerve involvement
- No
- Skin smear
- Negative
- Age in years
- 30
Result: Paucibacillary (PB) leprosy (1-5 lesions, no nerve involvement, no bacilli): rifampicin 600 mg once a month, clofazimine 300 mg once a month and 50 mg daily, and dapsone 100 mg daily, for 6 months (6 packs of 28 days).
The tool opens with these values already filled in. Replace them with your own.
What you enter
- Number of skin lesions
- Nerve involvement
- Skin smear
- Age in years
- Weight in kg (needed under 10 years or under 40 kg)
How this is calculated
Citation
WHO SEARO. Guidelines for the diagnosis, treatment and prevention of leprosy. New Delhi: WHO; 2018. Case definitions (pp. 1-2) and Table 3. Read the source ↗
A reference and educational tool. Not medical, legal, or financial advice, and not a substitute for clinician judgment.